Scripps 40th Annual New Treatments in Chronic Liver Disease 2026

• Target Audience: hepatologists, gastroenterologists, and transplant specialists
• Sample video: contact me for sample video
• Information:

1. Overview

Course Date: 2026

2. Learning Objectives

Upon completion of this activity, participants should be able to:

• Cite new strategies for identifying and managing metabolic liver disease.

• Discuss potential new treatments for alcohol-related liver disease.

• Summarize novel markers and therapies in PBC and PSC.

• Evaluate liver masses and new therapeutic options for HCC.

• Employ strategies for treating and managing ascites and hepatorenal syndrome.

3. Target Audience

Best for hepatologists, gastroenterologists, and transplant specialists who want updates on viral hepatitis, MASH, MetALD, and transplant criteria.

4. Topics

01 The Emerging Clinical Entity of MetALD Diagnosis, Risk, and Management

02 Treatment of MASH Cirrhosis Is it Reversible

03 Obesity Treatment The Essentials

04 Pediatric MASH Approaches to Diagnosis and Treatment VIDEO PDF NOT RELEASE

05 Panel Discussion Q&A

06 Updates on Diagnosis and Treatment of Autoimmune Hepatitis

07 Drug Induced Liver Injury

08 Hepatitis B Functional Cures

09 Using Medication Assisted Therapy in Hepatitis C

11 Panel Discussion Q&A

12 HCC VIDEO PDF NOT RELEASE

13 Transplant Selection Board

14 WILLIAM S. HAUBRICH LECTURE Updates in PBC and PSC

15 Panel Discussion Q&A